With this growing portfolio of integrated modules, the team is building a cohesive ecosystem that could enable the organization to efficiently generate benefits along the entire value chain. Novartis is using data analytics to research and develop new treatments. The company has been working with the University of California, San Francisco, on a project called Med-X, which aims to use big data analysis to help doctors better treat patients who have heart disease. Using machine learning and cognitive computing algorithms, the system can use past and present information from Novartis's massive data pool to make performance predictions, for example, for clinical studies, helping researchers choose the best sites and countries, and make faster and more informed decisions about trials.
Novartis is using data analytics to research and develop new treatments. The company has been working with the University of California, San Francisco, on a project called Med-X, which aims to use big data analysis to help doctors better treat patients who have heart disease. Using machine learning and cognitive computing algorithms, the system can use past and present information from Novartis's massive data pool to make performance predictions, for example, for clinical studies, helping researchers choose the best sites and countries, and make faster and more informed decisions about trials.